247
Participants
Start Date
May 31, 2009
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
imiquimod cream
Imiquimod 3.75% cream (250 mg/packet) up to 2 packets applied daily Two 2-week treatment periods (Cycle 1 and Cycle 2) separated by a 2-week no-treatment period
placebo cream
cream applied once daily for two 2-week treatment periods (Cycle 1 and Cycle 2) separated by a 2-week no-treatment period
DermResearchCenter of New York, Stony Brook
Wake Forest Univ School of Medicine, Winston-Salem
MedaPhase, Inc., Newnan
Palm Beach Dermatology, West Palm Beach
Spencer Dermatology & Skin Surgery Center, Saint Petersberg
Evanston Northwestern Healthcare, Skokie
Skin Specialists PC, Omaha
Dermatology Treatment and Research Center, Dallas
Progressive Clinical Research, San Antonio
DermResearch Inc., Austin
Academic Dermatology Association, Albuquerque
Dermatology Research Associates, Los Angeles
Therapeutics Clinical Research, San Diego
Oregon Medical Research Center, Portland
Guildford Dermatology Specialists, Surrey
Clinique de Dermatologie, Moncton
Ultranova Skincare, Barrie
Probity Medical Research, Waterloo
Lead Sponsor
Graceway Pharmaceuticals, LLC
INDUSTRY